Breast Cancer
Latest News in Breast Cancer
October 24, 2024
Osteopontin is a therapeutic target that drives breast cancer recurrence – Nature.com
October 13, 2024
October 10, 2024
3036 Active Breast Cancer Clinical Trials
3036 Active Breast Cancer Clinical Trials
As of November 12, 2024
Source: clinicaltrials.gov
LOCATE
CLINICAL TRIALS
BROWSE
FDA-approved DRUGS